Merit Medical Systems (MMSI) Return on Capital Employed (2011 - 2026)

Merit Medical Systems has disclosed Return on Capital Employed across 16 years of filings, most recently posting 1.57% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 1.57%, down 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.57% (down 6.0% YoY), and the FY2025 annual result was 1.55%, up 9.0% from the prior year.
• Return on Capital Employed came in at 1.57% for Q1 2026 at Merit Medical Systems, up from 1.48% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 7.38% in Q3 2023 to a low of 1.26% in Q4 2023.
• The 5-year median for Return on Capital Employed is 2.32% (2024), against an average of 3.48%.
• Across the five-year window, Return on Capital Employed jumped 354 bps in 2022 and slumped 523 bps in 2024, its largest moves.
• Merit Medical Systems' Return on Capital Employed stood at 6.13% in 2022, then plunged by 79 bps to 1.26% in 2023, then advanced by 14 bps to 1.44% in 2024, then climbed by 3 bps to 1.48% in 2025, then climbed by 6 bps to 1.57% in 2026.
• The last three Return on Capital Employed figures came in at 1.57% (Q1 2026), 1.48% (Q4 2025), and 1.8% (Q3 2025), per Business Quant data.